Gene Therapy - Table of Contents alert Volume 24 Issue 12

If you are unable to see the message below, click here to view.

Advertisement Need High Titer AAV for your pre-clinical research?    High Titer > 10e13-14 GC/ml research-grade and clinical viral vector production Delivered in 2 weeks Announcing: Gene therapy for CLN7 Batten Disease, Read Press Release Learn more about AAV services    TABLE OF CONTENTS Volume 24, Issue 12 (December 2017) In this issue News and Commentary Original Articles Short Communication Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe News and Commentary Minority report: targeting emerging viruses before their emergence B D Greenbaum & N Vabret Gene Therapy 2017 24: 755 - 756; October 06, 2017; 10.1038/gt.2017.93   Abstract | Full Text Original Articles Adipose tissue: a new target for electroporation-enhanced DNA vaccines P D Fisher, C J Brambila, J R McCoy, W B Kiosses, J M Mendoza et al. Gene Therapy 2017 24: 757 - 767; November 06, 2017; 10.1038/gt.2017.96   Abstract | Full Text Strategy to detect pre-existing immunity to AAV gene therapy L Falese, K Sandza, B Yates, S Triffault, S Gangar et al. Gene Therapy 2017 24: 768 - 778; November 06, 2017; 10.1038/gt.2017.95   Abstract | Full Text Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy Md T A Azad, S Bhakta& T Tsukahara Gene Therapy 2017 24: 779 - 786; December 07, 2017; 10.1038/gt.2017.90   Abstract | Full Text Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina D G Hickey, T L Edwards, A R Barnard, M S Singh, S R de Silva et al. Gene Therapy 2017 24: 787 - 800; November 16, 2017; 10.1038/gt.2017.85   Abstract | Full Text In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease L Chansel-Debordeaux, M Bourdenx, S Dovero, V Grouthier, N Dutheil et al. Gene Therapy 2017 24: 801 - 809; November 16, 2017; 10.1038/gt.2017.84   Abstract | Full Text Short Communication In situ regeneration of retinal pigment epithelium by gene transfer of E2F2: a potential strategy for treatment of macular degenerations D Kampik, M Basche, U F O Luhmann, K M Nishiguchi, J A E Williams et al. Gene Therapy 2017 24: 810 - 818; November 30, 2017; 10.1038/gt.2017.89   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.